Research project will use cervical cells to predict risk of cancersBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2999 (Published 02 June 2015) Cite this as: BMJ 2015;350:h2999
- Ingrid Torjesen
A European research project is aiming to develop new ways for testing cervical endothelial cells, collected during cervical screening tests, to predict women’s risk of breast, endometrial, and ovarian cancer as well as cervical cancer.
The FORECEE (4C) project involves 14 European research partners and has been awarded a €7.9m (£5.7m; $8.7m) grant by the European Commission and £1m by the Eve Appeal charity to enable it to use “multi-omics” to identify markers for the most aggressive types of the four cancers affecting women. Multi-omics means that the researchers use genome, epigenome (environmental factors that turn genes on and off and affect how cells …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial